{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:57:09Z","timestamp":1790629029453,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["EXA 871\/18"],"award-info":[{"award-number":["EXA 871\/18"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["EXA 769\/16"],"award-info":[{"award-number":["EXA 769\/16"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007070","name":"Universidad Nacional de Mar del Plata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.actatropica.2019.105215","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T18:05:49Z","timestamp":1570471549000},"page":"105215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?"],"prefix":"10.1016","volume":"201","author":[{"given":"Julia","family":"Fabbri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Eugenia","family":"Pensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Karina","family":"Medici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Ullio","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Celina","family":"Elissondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2019.105215_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pt.2007.01.003","article-title":"Drug transfer into target helminth parasites","volume":"23","author":"Alvarez","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2019.105215_bib0002","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4049\/jimmunol.162.2.995","article-title":"Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of \u03b3\u03b4 T cells","volume":"162","author":"Cardona","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2019.105215_bib0003","first-page":"679","article-title":"Population pharmacokinetics of albendazole in patients with neurocysticercosis","volume":"47","author":"Castro","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.actatropica.2019.105215_bib0004","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1208\/s12249-010-9517-6","article-title":"Improved albendazole dissolution rate in pluronic 188 solid dispersions","volume":"11","author":"Castro","year":"2010","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"12","key":"10.1016\/j.actatropica.2019.105215_bib0005","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1128\/AAC.05105-11","article-title":"Comparative performance of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma\/cysts disposition and efficacy in infected mice","volume":"55","author":"Ceballos","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105215_bib0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00436-008-0980-x","article-title":"Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations","volume":"103","author":"Ceballos","year":"2008","journal-title":"Parasitol. Res."},{"issue":"5","key":"10.1016\/j.actatropica.2019.105215_bib0007","doi-asserted-by":"crossref","first-page":"e2838","DOI":"10.1371\/journal.pntd.0002838","article-title":"Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations","volume":"8","author":"Ceballos","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2019.105215_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005153","article-title":"Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy","volume":"11","author":"Debacq","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2019.105215_bib0009","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1017\/S0022149X18000585","article-title":"Experimental murine model of neurocysticercosis: first report of cerebellum as a location for Mesocestoides corti tetrathyridia","volume":"93","author":"Fabbri","year":"2018","journal-title":"J. Helminthol."},{"issue":"6","key":"10.1016\/j.actatropica.2019.105215_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.parint.2013.08.009","article-title":"Novel albendazole formulations given during the intestinal phase of Trichinella spiralis infection reduce effectively parasitic muscle burden in mice","volume":"62","author":"Garc\u00eda","year":"2013","journal-title":"Parasitol. Int."},{"issue":"4","key":"10.1016\/j.actatropica.2019.105215_bib0011","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ncl.2018.07.003","article-title":"Neurocysticercosis","volume":"36","author":"Garcia","year":"2018","journal-title":"Neurol. Clin."},{"issue":"3","key":"10.1016\/j.actatropica.2019.105215_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.actatropica.2019.105215_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0378-5173(02)00559-8","article-title":"Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole","volume":"250","author":"Garc\u0131\u0301a","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105215_bib0014","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats","volume":"5","author":"Garcion","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actatropica.2019.105215_bib0015","series-title":"Pharmacokinetics","first-page":"45","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.actatropica.2019.105215_bib0016","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.actatropica.2016.11.015","article-title":"Neurocysticercosis infection and disease \u2013 a review","volume":"166","author":"Gripper","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2019.105215_bib0017","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2019.105215_bib0018","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/156802608783790811","article-title":"Medical treatment for neurocysticercosis: drugs, indications and perspectives","volume":"8","author":"Jung","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105215_bib0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/ecp.11.72","article-title":"Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis","volume":"5","author":"Jung-Cook","year":"2012","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105215_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105215_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/2210681206666160726164457","article-title":"Solid lipid nanoparticles of albendazole for treatment of Toxocara canis infection: in-vivo efficacy studies","volume":"7","author":"Kudtarkar","year":"2017","journal-title":"Nanosci. Nanotechnol. Asia"},{"key":"10.1016\/j.actatropica.2019.105215_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijpharm.2004.03.018","article-title":"Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment","volume":"278","author":"Lamprecht","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actatropica.2019.105215_bib0023","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pneurobio.2009.12.008","article-title":"Cysticercosis and neurocysticercosis as pathogens affecting the nervous system","volume":"91","author":"Mahanty","year":"2010","journal-title":"Prog. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.105215_bib0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2016.01.006","article-title":"A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties","volume":"499","author":"Martinez-Marcos","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105215_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(03)00369-7","article-title":"Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors","volume":"263","author":"Merino","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105215_bib0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2007.01.008","article-title":"Absorption and metabolism of albendazole after intestinal ischemia\/reperfusion","volume":"31","author":"Molina","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.105215_bib0027","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"4","key":"10.1016\/j.actatropica.2019.105215_bib0028","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jcph.1346","article-title":"Factors associated with cysticidal treatment response in extraparenchymal neurocysticercosis","volume":"59","author":"Osorio","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105215_bib0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.actatropica.2009.09.006","article-title":"Two novel ternary albendazole-cyclodextrin-polymer systems: dissolution, bioavailability and efficacy against Taenia crassiceps cysts","volume":"113","author":"Palomares-Alonso","year":"2010","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.actatropica.2019.105215_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4155\/tde-2017-0090","article-title":"Albendazole nanocrystals with improved pharmacokinetic performance in mice","volume":"9","author":"Paredes","year":"2018","journal-title":"Ther. Deliv."},{"issue":"6","key":"10.1016\/j.actatropica.2019.105215_bib0031","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"Peltier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2019.105215_bib0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.vetpar.2014.01.027","article-title":"Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis","volume":"203","author":"Pensel","year":"2014","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105215_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vetpar.2017.12.022","article-title":"Albendazole nanocrystals in experimental alveolar echinococcosis: enhanced chemoprophylactic and clinical efficacy in infected mice","volume":"251","author":"Pensel","year":"2018","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105215_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2015.09.016","article-title":"Cystic echinococcosis therapy: albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice","volume":"152","author":"Pensel","year":"2015","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.actatropica.2019.105215_bib0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1208\/s12249-016-0659-z","article-title":"Albendazole microcrystal formulations based on chitosan and cellulose derivatives: physicochemical characterization and in vitro parasiticidal activity in Trichinella spiralis adult worms","volume":"18","author":"Priotti","year":"2017","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.actatropica.2019.105215_bib0036","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"Roger","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.105215_bib0037","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2011.01.021","article-title":"Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration","volume":"79","author":"Roger","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2019.105215_bib0038","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J. Control Release"},{"key":"10.1016\/j.actatropica.2019.105215_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0001-706X(02)00027-X","article-title":"Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis","volume":"82","author":"Shuhua","year":"2002","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.actatropica.2019.105215_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.arcmed.2009.12.003","article-title":"Neurocysticercosis: changes after 25 years of medical therapy","volume":"41","author":"Sotelo","year":"2010","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.actatropica.2019.105215_bib0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2125.2002.01634.x","article-title":"Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis","volume":"54","author":"Takayanagui","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.actatropica.2019.105215_bib0042","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(97)00204-4","article-title":"A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation","volume":"156","author":"Torrado","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.actatropica.2019.105215_bib0043","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00436-016-4937-1","article-title":"Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications","volume":"115","author":"Ullio Gamboa","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2019.105215_bib0044","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exppara.2019.02.002","article-title":"Albendazole-lipid nanocapsules: optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus","volume":"198","author":"Ullio Gamboa","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105215_bib0045","series-title":"Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases. A Roadmap For Implementation","year":"2012"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19307132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19307132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:18:28Z","timestamp":1757549908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X19307132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"alternative-id":["S0001706X19307132"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105215","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105215"}}